Belite Bio Inc

NAS:BLTEHealthcarenasdaq_composite

$154.45+4.83%At closeAt close · Wed 21 Oct · ≈ AED 567.22 · Market cap $5.93B · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	81.8%	64.0%	−30.5%	−35.0%	−24.8%	−10.1%	−10.1%	+0.0 pts
Return on assets	−22.3%	−52.7%	−28.6%	−33.4%	−23.8%	−9.9%	−9.9%	+0.0 pts
Return on capital employed	−23.2%	−58.6%	−30.4%	−34.8%	−27.4%	−10.9%	—	—
Debt / equity	−4.5×	−2.1×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	123.6%	173.3%	2.0%	0.9%	0.4%	0.1%	—	—
Interest coverage	−273.5×	0.0×	−801.3×	−1,266.7×	−1,999.8×	0.0×	—	—
Current ratio	26.4×	10.7×	20.3×	24.8×	24.3×	50.0×	50.0×	+0.0%
Quick ratio	26.4×	10.7×	20.4×	24.8×	24.3×	50.0×	—	—
Cash ratio	26.4×	10.6×	20.0×	24.3×	5.2×	35.7×	35.7×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	—	—	0.0×	—	—	—	—	—
Receivables turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.